M056 hsv transverse myelitis in a patient on mepolizumab

Mepolizumab is a monoclonal antibody that inhibits IL-5 indicated as a maintenance treatment for severe eosinophilic asthma. Reactivation of the herpes zoster virus is a known adverse reaction of the drug. Here we present a patient who developed HSV transverse myelitis secondary to his mepolizumab treatment for severe asthma.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Source Type: research